The Santerre Lab is happy to welcome three new graduate students this coming Fall!
Dr. Paul Santerre Awarded the Lifetime Achievement Award from the Canadian Biomaterials Society
Perspectives from Santerre Lab Alumni
Santerre Lab to attend the upcoming World Biomaterials Congress
Santerre Lab secures CIHR grant to fund the continued development of a tissue-engineered vascular graft
An opportunity to discover a future in STEM
Students from the Santerre group, would like to thank the IBBME Discovery program for allowing them to be involved in yet another enriching outreach experience. The Discovery program was established in 2015, is a collaborative volunteering effort between graduate students and high school teachers from George Harvey Collegiate Institute and Western Technical Commercial School.
Evonik acquires division of Santerre Lab spinoff company, Interface Biologics Inc.
Cohesys awarded First Place at the annual Venture Cup
Santerre Lab welcomes new summer students
Cardiac Patch Project Featured in the University of Toronto Magazine
Cohesys takes first place at the 2019 RBC Innovation & Entrepreneurship pitch competition
'Building New Bonds in Biomaterials'
First place at Dentistry Research Day 2019
Perspectives from Santerre lab Alumni
Michael Floros launches Cohesys, a spin-off from the Santerre Lab
Farewell to our recent graduates!
Santerre lab members head to Japan for the 5th TERMIS World Congress
Doctoral candidates awarded NSERC Scholarships
Summer research experiences at the Santerre Lab
Dr Santerre appointed Baxter Chair of Health Technology and Commercialization
Dr Paul Santerre has been appointed the Baxter Chair of Health Technology and Commercialization, created through a $2.5 million -investment by the Baxter Corporation to the University Health Network to drive entrepreneurship and commercialization initiatives at both the University Health Network and the University of Toronto. Read more about his appointment here.